Dr. Benedict C. Albensi, PhD, BCMAS, CRQM is ranked as the leading dementia researcher in Manitoba. According to Expertscape.com, he is also in the top 2.5% of 99,650 published authors worldwide on Alzheimer Disease from 2007 through 2018 based on contributions from his latest 10 articles on the topic of Alzheimer’s Disease. See link: http://expertscape.com/au/alzheimer+disease/Albensi%2C+B+C .
He also holds the Everett Endowment Fund Chair (for Alzheimer’s research) and the Manitoba Dementia Research Chair and is a Full Professor of Pharmacology and Therapeutics at the University of Manitoba, Winnipeg, Canada. In addition, he is a core member in the Biomedical Engineering Program and a Principal Investigator in the Division of Neurodegenerative Disorders at St. Boniface Hospital Research. He is also a Research Affiliate for the University of Manitoba’s Centre on Aging and a Scientist at the Manitoba Institute for Child Health (MICH). He has held several Board Director appointments (Alzheimer’s Soc. Manitoba & Movement Ctr. of Manitoba) and current a Board Director for MitoCanada. He has generated more than 220 articles and oral presentations that include peer-reviewed experimental papers, invited book chapters, reviews, abstracts, non-peer-reviewed articles, and other neuroscience or neurology relevant manuscripts. See link: https://www.ncbi.nlm.nih.gov/myncbi/browse/collection/48835760/?sort=date&direction=descending.
Dr. Albensi completed his PhD in Neuroscience at the University of Utah’s School of Medicine in 1995. He obtained advanced training as a Postdoctoral Fellow at the Georgetown Institute of Cognitive and Computational Sciences (GICCS) at Georgetown University Medical Center where he worked with a high field MRI system for assessing brain trauma, memory, and its effect on structure and physiology. Thereafter he trained under Dr. Mark Mattson (most highly cited neuroscientist in the world – 2016) as a Postdoctoral Scholar at the Sanders-Brown Center on Aging at the University of Kentucky’s Medical School and studied neurochemical pathways in synaptic plasticity, memory, and head trauma. Subsequently, he participated in clinical trials research at Pfizer, Inc. in Ann Arbor, Michigan. He also has earned several clinical research certifications (BCMAS, CRQM, pharmacoeconomics) and leadership certifications (business management, healthcare leadership, etc.).
In addition he has been a member of several grant review panels around the world, including the NIH, CIHR, Alzheimer’s Society of Canada, Alzheimer’s Association (USA), Wellcome Trust, American Institute of Biological Sciences, DOD, Agence Nationale de la Recherche, and the U.S. Civilian Research & Development Foundation. Dr, Albensi is also the Associate Editor for the journal Brain Injury and an Associate Editor for the Journal of Alzheimer’s Disease. He is married and lives in Canada with his wife and four daughters.
This work is licensed under a Creative Commons Attribution 4.0 International License.